Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

KeyBanc, Morgan Stanley Slash Price Target On Colfax

Author: Akanksha Bakshi | March 15, 2022 03:07pm

Colfax Corp's (NYSE:CFX) price target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis's 2022 Investor Day to reflect broadly lower peer multiples.
The analyst maintained an Overweight rating on CFX shares.
Related: Colfax's Q4 Earnings
Morgan Stanley also lowered its price target on Colfax to $41 (an upside of 11%) from $45 while maintaining the Equal-Weight ratings on the shares.
Colfax recently announced the future composition of the board of the company, which will be renamed Enovis Corp., upon the consummation of the company's previously announced spin-off of its existing fabrication technology business, which will operate as ESAB Corp.
Colfax revealed an expected completion date of April 4, 2022, for the spin-off of ESAB Corp.
Price Action: CFX shares are trading higher by 1.97% at $36.77 on the last check Tuesday.

Posted In: CFX